Article
Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins.
PloS one - 1 Jan 2016
Boehm-Cagan Anat, Bar Roni, Harats Dror, Shaish Aviv, Levkovitz Hana, Bielicki John K, Johansson Jan O, Michaelson Daniel M
Abstract excerpt
Apolipoprotein E4 (apoE4), the leading genetic risk factor for Alzheimer's disease (AD), is less lipidated compared to the most common and AD-benign allele, apoE3. We have recently shown that i.p. injections of the ATP-binding cassette A1 (ABCA1) agonist peptide CS-6253 to apoE mice reverse the hypolipidation of apoE4 and the associated brain pathology and behavioral deficits. While in the brain apoE is the main...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
